Routinely collected blood tests can reflect underlying pathophysiological processes. We demonstrate that the dynamics of routinely collected blood tests hold prediction validity in acute Spinal Cord Injury (SCI). Using MIMIC data (n = 2615) for modeling…
Continue Reading
What You Should Know:
– Ultrahuman, the pioneering health optimization company behind the Ultrahuman Ring and M1 (an advanced Continuous Glucose Monitoring platform), today announced the nationwide expansion of Blood Vision, now available across 48…
Continue Reading
Rare gynecological tumors (RGTs) present major clinical challenges due to their low incidence and heterogeneity. The lack of clear guidelines leads to suboptimal management and poor prognosis. Molecular tumor boards accelerate access to effective…
Continue Reading
Immunohistochemistry (IHC) is crucial for the clinical categorisation of breast cancer cases. Deep generative models may offer a cost-effective alternative by virtually generating IHC images from hematoxylin and eosin samples. This review explores the…
Continue Reading
As digital biomarkers gain traction in Alzheimer’s disease (AD) diagnosis, understanding recent advancements is crucial. This review conducts a bibliometric analysis of 431 studies from five online databases: Web of Science, PubMed, Embase, IEEE…
Continue Reading
Ellipsis Health, a company using AI voice agent technology, announced the close of a $45 million Series A funding roundSalesforce, Khosla Ventures and CVS Health Ventures led the round. Mitsui Global Investment, Collier, E12…
Continue Reading
Retinal age has emerged as a promising biomarker of aging, offering a non-invasive and accessible assessment tool. We developed a deep learning model to estimate retinal age with enhanced accuracy, leveraging retinal images from…
Continue Reading
Neurological conditions, including dementia, pose a major public health challenge, contributing to a significant and growing clinical, economic, and societal burden. Traditionally, research and clinical practice have focused on diseases like dementia in isolation….
Continue Reading
What You Should Know:
– Oxford Cancer Biomarkers Ltd (OCB), a leader in molecular precision cancer diagnostic tests, has today announced a new partnership with Mira Precision Health Inc.
– This collaboration aims to advance OCB’s…
Continue Reading
Phase Scientific, a company developing urine-based diagnostics tests for early disease detection, announced it completed a $34 million Series A funding round. A private equity fund managed by Asia-based Value Partners Group led the round,…
Continue Reading
